Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants.
Six ebolavirus species are reported to date, including human pathogens Bundibugyo virus (BDBV), Ebola virus (EBOV), Sudan virus (SUDV), and Taï Forest virus (TAFV); non-human pathogen Reston virus (RESTV); and the plausible Bombali virus (BOMV). Since there are differences in the disease severity ca...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-11-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010039&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839623168513277952 |
|---|---|
| author | Qingbo Shu Tara Kenny Jia Fan Christopher J Lyon Lisa H Cazares Tony Y Hu |
| author_facet | Qingbo Shu Tara Kenny Jia Fan Christopher J Lyon Lisa H Cazares Tony Y Hu |
| author_sort | Qingbo Shu |
| collection | DOAJ |
| description | Six ebolavirus species are reported to date, including human pathogens Bundibugyo virus (BDBV), Ebola virus (EBOV), Sudan virus (SUDV), and Taï Forest virus (TAFV); non-human pathogen Reston virus (RESTV); and the plausible Bombali virus (BOMV). Since there are differences in the disease severity caused by different species, species identification and viral burden quantification are critical for treating infected patients timely and effectively. Here we developed an immunoprecipitation-coupled mass spectrometry (IP-MS) assay for VP40 antigen detection and quantification. We carefully selected two regions of VP40, designated as peptide 8 and peptide12 from the protein sequence that showed minor variations among Ebolavirus species through MS analysis of tryptic peptides and antigenicity prediction based on available bioinformatic tools, and generated high-quality capture antibodies pan-specific for these variant peptides. We applied this assay to human plasma spiked with recombinant VP40 protein from EBOV, SUDV, and BDBV and virus-like particles (VLP), as well as EBOV infected NHP plasma. Sequence substitutions between EBOV and SUDV, the two species with highest lethality, produced affinity variations of 2.6-fold for p8 and 19-fold for p12. The proposed IP-MS assay differentiates four of the six known EBV species in one assay, through a combination of p8 and p12 data. The IP-MS assay limit of detection (LOD) using multiple reaction monitoring (MRM) as signal readout was determined to be 28 ng/mL and 7 ng/mL for EBOV and SUDV respectively, equivalent to ~1.625-6.5×105 Geq/mL, and comparable to the LOD of lateral flow immunoassays currently used for Ebola surveillance. The two peptides of the IP-MS assay were also identified by their tandem MS spectra using a miniature MALDI-TOF MS instrument, greatly increasing the feasibility of high specificity assay in a decentralized laboratory. |
| format | Article |
| id | doaj-art-a34f638c6e5c42bc8be2c3586f6abb08 |
| institution | Matheson Library |
| issn | 1553-7366 1553-7374 |
| language | English |
| publishDate | 2021-11-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Pathogens |
| spelling | doaj-art-a34f638c6e5c42bc8be2c3586f6abb082025-07-21T05:31:18ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742021-11-011711e101003910.1371/journal.ppat.1010039Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants.Qingbo ShuTara KennyJia FanChristopher J LyonLisa H CazaresTony Y HuSix ebolavirus species are reported to date, including human pathogens Bundibugyo virus (BDBV), Ebola virus (EBOV), Sudan virus (SUDV), and Taï Forest virus (TAFV); non-human pathogen Reston virus (RESTV); and the plausible Bombali virus (BOMV). Since there are differences in the disease severity caused by different species, species identification and viral burden quantification are critical for treating infected patients timely and effectively. Here we developed an immunoprecipitation-coupled mass spectrometry (IP-MS) assay for VP40 antigen detection and quantification. We carefully selected two regions of VP40, designated as peptide 8 and peptide12 from the protein sequence that showed minor variations among Ebolavirus species through MS analysis of tryptic peptides and antigenicity prediction based on available bioinformatic tools, and generated high-quality capture antibodies pan-specific for these variant peptides. We applied this assay to human plasma spiked with recombinant VP40 protein from EBOV, SUDV, and BDBV and virus-like particles (VLP), as well as EBOV infected NHP plasma. Sequence substitutions between EBOV and SUDV, the two species with highest lethality, produced affinity variations of 2.6-fold for p8 and 19-fold for p12. The proposed IP-MS assay differentiates four of the six known EBV species in one assay, through a combination of p8 and p12 data. The IP-MS assay limit of detection (LOD) using multiple reaction monitoring (MRM) as signal readout was determined to be 28 ng/mL and 7 ng/mL for EBOV and SUDV respectively, equivalent to ~1.625-6.5×105 Geq/mL, and comparable to the LOD of lateral flow immunoassays currently used for Ebola surveillance. The two peptides of the IP-MS assay were also identified by their tandem MS spectra using a miniature MALDI-TOF MS instrument, greatly increasing the feasibility of high specificity assay in a decentralized laboratory.https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010039&type=printable |
| spellingShingle | Qingbo Shu Tara Kenny Jia Fan Christopher J Lyon Lisa H Cazares Tony Y Hu Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants. PLoS Pathogens |
| title | Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants. |
| title_full | Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants. |
| title_fullStr | Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants. |
| title_full_unstemmed | Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants. |
| title_short | Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants. |
| title_sort | species specific quantification of circulating ebolavirus burden using vp40 derived peptide variants |
| url | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010039&type=printable |
| work_keys_str_mv | AT qingboshu speciesspecificquantificationofcirculatingebolavirusburdenusingvp40derivedpeptidevariants AT tarakenny speciesspecificquantificationofcirculatingebolavirusburdenusingvp40derivedpeptidevariants AT jiafan speciesspecificquantificationofcirculatingebolavirusburdenusingvp40derivedpeptidevariants AT christopherjlyon speciesspecificquantificationofcirculatingebolavirusburdenusingvp40derivedpeptidevariants AT lisahcazares speciesspecificquantificationofcirculatingebolavirusburdenusingvp40derivedpeptidevariants AT tonyyhu speciesspecificquantificationofcirculatingebolavirusburdenusingvp40derivedpeptidevariants |